{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:24:26Z","timestamp":1793730266615,"version":"4.6.1"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.meegid.2025.105853","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T15:14:34Z","timestamp":1763651674000},"page":"105853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats"],"prefix":"10.1016","volume":"136","author":[{"given":"Alireza","family":"Neshani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosna","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooshin Sadat","family":"Ghiasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Hosseini Bafghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0005","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1182\/blood.V96.9.3086","article-title":"The human antimicrobial and chemotactic peptides LL-37 and \u03b1-defensins are expressed by specific lymphocyte and monocyte populations","volume":"96","author":"Agerberth","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cbdd.13381","article-title":"The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli","volume":"93","author":"Aghazadeh","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.meegid.2025.105853_bb0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2019.02.002","article-title":"Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections","volume":"164","author":"Ahmed","year":"2019","journal-title":"Antivir. Res."},{"issue":"8","key":"10.1016\/j.meegid.2025.105853_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14715\/cmb\/2024.70.8.1","article-title":"Human cathelicidin, LL-37 a potential antiviral therapeutic for Rift Valley fever virus in Egypt","volume":"70","author":"Ahmed","year":"2024","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.meegid.2025.105853_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.peptides.2017.04.002","article-title":"In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2","volume":"92","author":"Alagarasu","year":"2017","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00284-022-02767-y","article-title":"Antimicrobial peptides as a promising therapeutic strategy for Neisseria infections","volume":"79","author":"Askari","year":"2022","journal-title":"Curr. Microbiol."},{"issue":"16","key":"10.1016\/j.meegid.2025.105853_bb0035","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1128\/AEM.00989-14","article-title":"Nonperturbative imaging of nucleoid morphology in live bacterial cells during an antimicrobial peptide attack","volume":"80","author":"Bakshi","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"issue":"16","key":"10.1016\/j.meegid.2025.105853_bb0040","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1073\/pnas.95.16.9541","article-title":"The peptide antibiotic LL-37\/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface","volume":"95","author":"Bals","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/biof.1225","article-title":"Unique features of human cathelicidin LL-37","volume":"41","author":"Bandurska","year":"2015","journal-title":"Biofactors"},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0050","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1462-5822.2005.00530.x","article-title":"Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37","volume":"7","author":"Bergman","year":"2005","journal-title":"Cell. Microbiol."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/biom14030320","article-title":"LL-37: structures, antimicrobial activity, and influence on amyloid-related diseases","volume":"14","author":"Bhattacharjya","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003862","article-title":"Snake cathelicidin NA-CATH and Smaller helical antimicrobial peptides are effective against Burkholderia thailandensis","volume":"9","author":"Blower","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/21505594.2017.1293227","article-title":"Cathelicidin peptide rescues G. mellonella infected with B. anthracis","volume":"9","author":"Blower","year":"2018","journal-title":"Virulence"},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0070","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.4049\/jimmunol.174.7.4271","article-title":"Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities","volume":"174","author":"Braff","year":"2005","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.meegid.2025.105853_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00745-17","article-title":"The Opp (AmiACDEF) oligopeptide transporter mediates resistance of serotype 2 Streptococcus pneumoniae D39 to killing by chemokine CXCL10 and other antimicrobial peptides","volume":"200","author":"Bruce","year":"2018","journal-title":"J. Bacteriol."},{"issue":"10","key":"10.1016\/j.meegid.2025.105853_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/08927014.2017.1370087","article-title":"KR-12-a5 is a non-cytotoxic agent with potent antimicrobial effects against oral pathogens","volume":"33","author":"Caiaffa","year":"2017","journal-title":"Biofouling"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.jid.5701043","article-title":"In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37","volume":"128","author":"Carretero","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.meegid.2025.105853_bb0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/B978-0-443-15393-8.00016-6","article-title":"Packaging, long-term stability, and usability of antimicrobial peptide products","author":"Castellanos","year":"2025","journal-title":"Antimicrob. Pept."},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000317665","article-title":"Specificity in killing pathogens is mediated by distinct repertoires of human neutrophil peptides","volume":"2","author":"Cederlund","year":"2010","journal-title":"J. Innate Immun."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0100","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1042\/BJ20111454","article-title":"LL37 and hBD-3 elevate the \u03b2-1, 3-exoglucanase activity of Candida albicans Xog1p, resulting in reduced fungal adhesion to plastic","volume":"441","author":"Chang","year":"2012","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0105","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3390\/v14071552","article-title":"Antiviral effect of hBD-3 and LL-37 during human primary keratinocyte infection with west nile virus","volume":"14","author":"Chessa","year":"2022","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0110","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/AAC.49.7.2845-2850.2005","article-title":"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37","volume":"49","author":"Ciornei","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.meegid.2025.105853_bb0115","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1073\/pnas.0900244106","article-title":"The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells","volume":"106","author":"Coffelt","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-5793(95)00634-L","article-title":"hCAP-18, a cathelin\/pro-bactenecin-like protein of human neutrophil specific granules","volume":"368","author":"Cowland","year":"1995","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.meegid.2025.105853_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073659","article-title":"The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus","volume":"8","author":"Currie","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.meegid.2025.105853_bb0130","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1021\/acs.biochem.8b01297","article-title":"The C-terminal VPRTES tail of LL-37 influences the mode of attachment to a lipid bilayer and antimicrobial activity","volume":"58","author":"de Miguel","year":"2019","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.meegid.2025.105853_bb0135","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.peptides.2010.07.028","article-title":"A carpet-based mechanism for direct antimicrobial peptide activity against vaccinia virus membranes","volume":"31","author":"Dean","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.meegid.2025.105853_bb0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fmicb.2011.00128","article-title":"Susceptibility of Pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37","volume":"2","author":"Dean","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2025.105853_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105368","article-title":"Efficacy of antimicrobial peptide LL-37 against biofilm forming Staphylococcus aureus strains obtained from chronic wound infections","volume":"162","author":"Demirci","year":"2022","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0150","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/BJ20042099","article-title":"Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane","volume":"388","author":"den Hertog","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.meegid.2025.105853_bb0155","series-title":"The Human Cathelicidin Peptide LL-37 and Truncated Variants Induce Segregation of Lipids and Proteins in the Plasma Membrane of Candida albicans","author":"den Hertog","year":"2006"},{"issue":"10\u221211","key":"10.1016\/j.meegid.2025.105853_bb0160","first-page":"1495","article-title":"The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans","volume":"387","author":"den Hertog","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.meegid.2025.105853_bb0165","first-page":"1","article-title":"In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria","author":"Denardi","year":"2022","journal-title":"Braz. J. Microbiol."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s42770-022-00678-5","article-title":"Anti-Pythium insidiosum activity of MSI-78, LL-37, and magainin-2 antimicrobial peptides","volume":"53","author":"Denardi","year":"2022","journal-title":"Braz. J. Microbiol."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0175","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.4049\/jimmunol.170.5.2274","article-title":"Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide","volume":"170","author":"Di Nardo","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1523-1747.2001.01340.x","article-title":"Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group a streptococcus","volume":"117","author":"Dorschner","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaad.2003.09.010","article-title":"Innate immune defense of the nail unit by antimicrobial peptides","volume":"50","author":"Dorschner","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.meegid.2025.105853_bb0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.peptides.2014.09.021","article-title":"Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides","volume":"62","author":"Dosler","year":"2014","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.meegid.2025.105853_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003620","article-title":"Role of the Vibrio cholerae matrix protein Bap1 in cross-resistance to antimicrobial peptides","volume":"9","author":"Duperthuy","year":"2013","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157242","article-title":"Candidacidal activity of selected ceragenins and human cathelicidin LL-37 in experimental settings mimicking infection sites","volume":"11","author":"Durna\u015b","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0205","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-017-1075-6","article-title":"Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo","volume":"17","author":"Durna\u015b","year":"2017","journal-title":"BMC Microbiol."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0210","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10765.x","article-title":"Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa\/acne inversa","volume":"166","author":"Emelianov","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.meegid.2025.105853_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114398","article-title":"Biodistribution of the cationic host defense peptide LL-37 using SPECT\/CT","volume":"202","author":"Esposito","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.meegid.2025.105853_bb0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.peptides.2013.09.007","article-title":"The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii","volume":"49","author":"Feng","year":"2013","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2012.01.013","article-title":"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II","volume":"33","author":"Fox","year":"2012","journal-title":"Peptides"},{"issue":"24","key":"10.1016\/j.meegid.2025.105853_bb0230","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1074\/jbc.272.24.15258","article-title":"The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders","volume":"272","author":"Frohm","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0235","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1128\/IAI.01197-07","article-title":"Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin","volume":"76","author":"Galv\u00e1n","year":"2008","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12866-019-1416-8","article-title":"Cationic antimicrobial peptides: alternatives and\/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa","volume":"19","author":"Geitani","year":"2019","journal-title":"BMC Microbiol."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0245","first-page":"69","article-title":"The antibacterial activity of LL-37 peptide against multidrug-resistant Pseudomonas aeruginosa isolated from burn infections","volume":"8","author":"F","year":"2023","journal-title":"Revista Bionatura."},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70212","article-title":"Anti-inflammatory peptides as promising therapeutics agent against inflammatory bowel diseases: a systematic review","volume":"9","author":"Ghazvini","year":"2025","journal-title":"JGH Open."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0255","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/02713680590934111","article-title":"Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity","volume":"30","author":"Gordon","year":"2005","journal-title":"Curr. Eye Res."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0260","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2340\/00015555-1102","article-title":"Stability of the cathelicidin peptide LL-37 in a non-healing wound environment","volume":"91","author":"Gr\u00f6nberg","year":"2011","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0265","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1432-1033.1996.0325z.x","article-title":"The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes","volume":"238","author":"Gudmundsson","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.meegid.2025.105853_bb0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fmicb.2020.00168","article-title":"Backbone cyclization and dimerization of LL-37-derived peptides enhance antimicrobial activity and proteolytic stability","volume":"11","author":"Gunasekera","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2025.105853_bb0275","article-title":"Backbone cyclization and dimerization of LL-37-derived peptides enhance antimicrobial activity and proteolytic stability","volume":"11\u20132020","author":"Gunasekera","year":"2020","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0280","article-title":"Antimicrobial and antibiofilm activity of human cationic antibacterial peptide (Ll-37) and its analogs against Pan-drug-resistant Acinetobacter baumannii. Jundishapur","volume":"10","author":"Guo","year":"2017","journal-title":"J. Microbiol."},{"key":"10.1016\/j.meegid.2025.105853_bb0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fchem.2019.00043","article-title":"Reassessing the host defense peptide landscape","volume":"7","author":"Haney","year":"2019","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0290","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/IAI.70.2.953-963.2002","article-title":"Cell differentiation is a key determinant of cathelicidin LL-37\/human cationic antimicrobial protein 18 expression by human colon epithelium","volume":"70","author":"Hase","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.meegid.2025.105853_bb0295","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fmicb.2019.00210","article-title":"Proteomic analysis of resistance of gram-negative bacteria to chlorhexidine and impacts on susceptibility to colistin, antimicrobial peptides, and ceragenins","volume":"10","author":"Hashemi","year":"2019","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1472-765X.2009.02778.x","article-title":"Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis","volume":"50","author":"Hell","year":"2010","journal-title":"Lett. Appl. Microbiol."},{"issue":"21","key":"10.1016\/j.meegid.2025.105853_bb0305","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1021\/bi0273563","article-title":"Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37","volume":"42","author":"Henzler Wildman","year":"2003","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0310","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.peptides.2005.01.020","article-title":"Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens","volume":"26","author":"Herasimenka","year":"2005","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126994","article-title":"Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipids","volume":"10","author":"Honda","year":"2015","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.meegid.2025.105853_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910633","article-title":"Candida albicans Sfp1 is involved in the cell wall and endoplasmic reticulum stress responses induced by human antimicrobial peptide LL-37","volume":"22","author":"Hsu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085765","article-title":"Antimicrobial cathelicidin peptide LL-37 inhibits the LPS\/ATP-induced pyroptosis of macrophages by dual mechanism","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2025.105853_bb0330","series-title":"The Mechanism of Action of LL-37 Revisited: Exploring its Activity and Interaction with the Gram-Positive Model Organism Bacillus subtilis","author":"Humphrey","year":"2024"},{"key":"10.1016\/j.meegid.2025.105853_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104700","article-title":"Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates","volume":"150","author":"Jahangiri","year":"2021","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0340","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12602-018-9444-5","article-title":"Antimicrobial activity of selected antimicrobial peptides against planktonic culture and biofilm of Acinetobacter baumannii","volume":"11","author":"Ja\u015bkiewicz","year":"2019","journal-title":"Probiotics Antimicrob. Proteins."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0345","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0765.2006.00962.x","article-title":"Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils","volume":"42","author":"Ji","year":"2007","journal-title":"J. Periodontal Res."},{"issue":"12","key":"10.1016\/j.meegid.2025.105853_bb0350","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/JB.01313-08","article-title":"Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37","volume":"191","author":"Jones","year":"2009","journal-title":"J. Bacteriol."},{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0355","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/psc.2434","article-title":"Synthesis, biological activity and conformational analysis of head-to-tail cyclic analogues of LL37 and histatin 5","volume":"18","author":"Kamysz","year":"2012","journal-title":"J. Pept. Sci."},{"issue":"12","key":"10.1016\/j.meegid.2025.105853_bb0360","first-page":"2175","article-title":"Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae","volume":"33","author":"Kiattiburut","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.meegid.2025.105853_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13062-016-0159-9","article-title":"IPC\u2013isoelectric point calculator","volume":"11","author":"Kozlowski","year":"2016","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00253-010-2736-7","article-title":"High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli","volume":"88","author":"Krahulec","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0375","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/jac\/dkv487","article-title":"Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia","volume":"71","author":"Kumaraswamy","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0380","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijantimicag.2017.12.032","article-title":"Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies","volume":"51","author":"Kumaraswamy","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0385","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0006-291X(91)91350-L","article-title":"Complementary DNA sequence of rabbit CAP18\u2014a unique lipopolysaccharide binding protein","volume":"179","author":"Larrick","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.meegid.2025.105853_bb0390","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2468","article-title":"Antimicrobial activity of Tachyplesin 1 against Burkholderia pseudomallei: an in vitro and in silico approach","volume":"4","author":"Lee","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.meegid.2025.105853_bb0395","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2180-9-187","article-title":"Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice","volume":"9","author":"Leszczy\u0144ska","year":"2009","journal-title":"BMC Microbiol."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0400","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/jac\/dks434","article-title":"Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections","volume":"68","author":"Leszczynska","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0405","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QAD.0b013e328321809c","article-title":"Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition","volume":"23","author":"Levinson","year":"2009","journal-title":"Aids"},{"key":"10.1016\/j.meegid.2025.105853_bb0410","series-title":"Characterization of Polymicrobial Infections in Macaques with Chronic Cranial Implants and Evaluation of Alternative Antimicrobial Strategies","author":"Lieberman","year":"2018"},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0415","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","article-title":"Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens","volume":"2","author":"Lin","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.meegid.2025.105853_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105248","article-title":"Endogenous cathelicidin is required for protection against ZIKV-caused testis damage via inactivating virons","volume":"198","author":"Liu","year":"2022","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0425","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.0022-202X.2005.23713.x","article-title":"Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection","volume":"125","author":"L\u00f3pez-Garc\u00eda","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0430","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jac\/dkl078","article-title":"Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolor","volume":"57","author":"L\u00f3pez-Garc\u00eda","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2025.105853_bb0435","doi-asserted-by":"crossref","first-page":"944147","DOI":"10.3389\/fphar.2022.944147","article-title":"Renovation as innovation: repurposing human antibacterial peptide LL-37 for cancer therapy","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.meegid.2025.105853_bb0440","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2019.00283","article-title":"LL37 inhibits aspergillus fumigatus infection via directly binding to the fungus and preventing excessive inflammation","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.meegid.2025.105853_bb0445","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/fermentation10110540","article-title":"A review of antimicrobial peptides: structure, mechanism of action, and molecular optimization strategies","volume":"10","author":"Ma","year":"2024","journal-title":"Fermentation"},{"key":"10.1016\/j.meegid.2025.105853_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2021.107842","article-title":"Interaction of LL-37 human cathelicidin peptide with a model microbial-like lipid membrane","volume":"141","author":"Majewska","year":"2021","journal-title":"Bioelectrochemistry"},{"issue":"12","key":"10.1016\/j.meegid.2025.105853_bb0455","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.chembiol.2014.10.009","article-title":"The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis","volume":"21","author":"Mardirossian","year":"2014","journal-title":"Chem. Biol."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0460","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12088-019-00800-6","article-title":"Differential expression of the apsXRS system by antimicrobial peptide LL-37 in commensal and clinical Staphylococcus epidermidis isolates","volume":"59","author":"Mart\u00ednez-Garc\u00eda","year":"2019","journal-title":"Indian J. Microbiol."},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0465","first-page":"1214","article-title":"Salmonella membrane structural remodeling increases resistance to antimicrobial peptide LL-37. ACS","volume":"5","author":"Martynowycz","year":"2019","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.meegid.2025.105853_bb0470","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10989-014-9410-3","article-title":"The host defence peptide LL-37 is susceptible to proteolytic degradation by wound fluid isolated from foot ulcers of diabetic patients","volume":"20","author":"McCrudden","year":"2014","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0475","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1128\/AAC.00016-11","article-title":"Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37","volume":"55","author":"McGee","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0480","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.anaerobe.2012.09.004","article-title":"Clostridium difficile clinical isolates exhibit variable susceptibility and proteome alterations upon exposure to mammalian cationic antimicrobial peptides","volume":"18","author":"McQuade","year":"2012","journal-title":"Anaerobe"},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0485","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11274-023-03545-z","article-title":"Antibiofilm properties of cathelicidin LL-37: an in-depth review","volume":"39","author":"Memariani","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0490","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/s41598-017-04462-6","article-title":"Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism","volume":"7","author":"Menzel","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0495","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00403-023-02657-8","article-title":"Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trial","volume":"315","author":"Miranda","year":"2023","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0500","first-page":"561","article-title":"Antibiotic resistance crisis","volume":"40","author":"Mobarki","year":"2019","journal-title":"Int. J. Med. Dev. Ctries."},{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0505","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbamem.2006.02.003","article-title":"Expression and purification of a recombinant LL-37 from Escherichia coli","volume":"1758","author":"Moon","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.meegid.2025.105853_bb0510","doi-asserted-by":"crossref","first-page":"100900","DOI":"10.1016\/j.genrep.2020.100900","article-title":"Construction, cloning, and expression of Melittin antimicrobial peptide using Pichia pastoris expression system","volume":"21","author":"Moridi","year":"2020","journal-title":"Gene Reports."},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0515","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2217\/fmb-2020-0204","article-title":"Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates","volume":"16","author":"Morroni","year":"2021","journal-title":"Future Microbiol."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0520","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.4049\/jimmunol.172.5.3070","article-title":"Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense","volume":"172","author":"Murakami","year":"2004","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.meegid.2025.105853_bb0525","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/JB.01222-09","article-title":"Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis","volume":"192","author":"Naito","year":"2010","journal-title":"J. Bacteriol."},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0530","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.peptides.2012.04.004","article-title":"Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37","volume":"35","author":"Nan","year":"2012","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0535","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.peptides.2005.09.016","article-title":"Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application","volume":"27","author":"Nell","year":"2006","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0540","article-title":"Extended-Spectrum antimicrobial activity of the low cost produced Tilapia Piscidin 4 (TP4) marine antimicrobial peptide","volume":"6","author":"Neshani","year":"2018","journal-title":"J. Res. Med. Dent. Sci."},{"key":"10.1016\/j.meegid.2025.105853_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2019.100509","article-title":"Preparation and evaluation of a new biopesticide solution candidate for plant disease control using pexiganan gene and Pichia pastoris expression system","volume":"17","author":"Neshani","year":"2019","journal-title":"Gene Reports."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0550","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12555","article-title":"Review of antimicrobial peptides with anti-Helicobacter pylori activity","volume":"24","author":"Neshani","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.meegid.2025.105853_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-019-0309-7","article-title":"Epinecidin-1, a highly potent marine antimicrobial peptide with anticancer and immunomodulatory activities","volume":"20","author":"Neshani","year":"2019","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.meegid.2025.105853_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2019.100519","article-title":"LL-37: review of antimicrobial profile against sensitive and antibiotic-resistant human bacterial pathogens","volume":"17","author":"Neshani","year":"2019","journal-title":"Gene Reports."},{"key":"10.1016\/j.meegid.2025.105853_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104238","article-title":"Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections","volume":"146","author":"Neshani","year":"2020","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0570","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1038\/s41598-017-04653-1","article-title":"Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13","volume":"7","author":"Niemirowicz","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0575","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.01670-13","article-title":"Fungicidal mechanisms of cathelicidins LL-37 and CATH-2 revealed by live-cell imaging","volume":"58","author":"Ordonez","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0580","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/IAI.00318-08","article-title":"Human host defense peptide LL-37 prevents bacterial biofilm formation","volume":"76","author":"Overhage","year":"2008","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.24087","article-title":"Effect of targeted minimal sequence variations on the structure and biological activities of the human cathelicidin LL-37","volume":"110","author":"Pacor","year":"2018","journal-title":"Pept. Sci."},{"key":"10.1016\/j.meegid.2025.105853_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199496","article-title":"Antiviral activity of cathelicidins against porcine epidemic diarrhea virus (PEDV): mechanisms, and efficacy","volume":"350","author":"Pashaie","year":"2024","journal-title":"Virus Res."},{"issue":"8","key":"10.1016\/j.meegid.2025.105853_bb0595","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/antibiotics13080764","article-title":"Antimicrobial properties and cytotoxicity of LL-37-derived synthetic peptides to treat orthopedic infections","volume":"13","author":"Pennone","year":"2024","journal-title":"Antibiotics"},{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0600","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.peptides.2011.08.002","article-title":"Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients","volume":"32","author":"Pompilio","year":"2011","journal-title":"Peptides"},{"issue":"12","key":"10.1016\/j.meegid.2025.105853_bb0605","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/metabo14120672","article-title":"Cathelicidin: insights into its impact on metabolic syndrome and chronic inflammation","volume":"14","author":"Popa","year":"2024","journal-title":"Metabolites"},{"issue":"20","key":"10.1016\/j.meegid.2025.105853_bb0610","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1021\/bi702036s","article-title":"NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles","volume":"47","author":"Porcelli","year":"2008","journal-title":"Biochemistry"},{"issue":"15","key":"10.1016\/j.meegid.2025.105853_bb0615","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1021\/acs.biochem.5c00101","article-title":"\u03b1-Helical structure of antimicrobial peptides enhances their activity through molecular surface signatures","volume":"64","author":"Quagliata","year":"2025","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0620","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbamem.2018.06.016","article-title":"Antimicrobial and anti-inflammatory activities of chemokine CXCL14-derived antimicrobial peptide and its analogs","volume":"1861","author":"Rajasekaran","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes."},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0625","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/jof8020204","article-title":"Antifungal activity of human cathelicidin LL-37, a membrane disrupting peptide, by triggering oxidative stress and cell cycle arrest in Candida auris","volume":"8","author":"Rather","year":"2022","journal-title":"J. Fungi."},{"issue":"5","key":"10.1016\/j.meegid.2025.105853_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063641","article-title":"FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and Autophagic cell death in Colon Cancer cells","volume":"8","author":"Ren","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0635","article-title":"The potential of human peptide LL-37 as an antimicrobial and anti-biofilm agent","volume":"10","author":"Ridyard","year":"2021","journal-title":"Antibiotics (Basel)."},{"key":"10.1016\/j.meegid.2025.105853_bb0640","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2180-10-61","article-title":"Differential activity of innate defense antimicrobial peptides against Nocardia species","volume":"10","author":"Rieg","year":"2010","journal-title":"BMC Microbiol."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0645","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/IAI.01218-07","article-title":"Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells","volume":"76","author":"Rivas-Santiago","year":"2008","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0650","doi-asserted-by":"crossref","first-page":"545a","DOI":"10.1016\/j.bpj.2023.11.3301","article-title":"Energetics of toroidal pore formation in lipid membranes using molecular dynamics simulations","volume":"123","author":"Rivel","year":"2024","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0655","article-title":"Antimicrobial peptides: a promising alternative to conventional antimicrobials for combating Polymicrobial biofilms","volume":"12","author":"Roque-Borda","year":"2025","journal-title":"Adv. Sci. (Weinh)."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0660","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.intimp.2013.01.012","article-title":"Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages","volume":"15","author":"Ruan","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.meegid.2025.105853_bb0665","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1128\/AAC.00486-15","article-title":"Differential effects of penicillin binding protein deletion on the susceptibility of enterococcus faecium to cationic peptide antibiotics","volume":"59","author":"Sakoulas","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0670","doi-asserted-by":"crossref","first-page":"e00410","DOI":"10.1128\/mSphere.00410-17","article-title":"Interaction of antibiotics with innate host defense factors against Salmonella enterica serotype newport","volume":"2","author":"Sakoulas","year":"2017","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0675","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1038\/s41598-017-14206-1","article-title":"Structural remodeling and oligomerization of human cathelicidin on membranes suggest fibril-like structures as active species","volume":"7","author":"Sancho-Vaello","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0680","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.1038\/s41598-020-74401-5","article-title":"The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics","volume":"10","author":"Sancho-Vaello","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0685","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/antibiotics3030353","article-title":"Ciprofloxacin affects host cells by suppressing expression of the endogenous antimicrobial peptides cathelicidins and beta-defensin-3 in colon epithelia","volume":"3","author":"Sarker","year":"2014","journal-title":"Antibiotics (Basel)."},{"key":"10.1016\/j.meegid.2025.105853_bb0690","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.peptides.2015.07.023","article-title":"Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections","volume":"71","author":"Scarsini","year":"2015","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0695","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41246-6","article-title":"Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action","volume":"9","author":"Scheenstra","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0700","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1568026615666150703121009","article-title":"Non-membrane permeabilizing modes of action of antimicrobial peptides on bacteria","volume":"16","author":"Scocchi","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0705","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses1","volume":"169","author":"Scott","year":"2002","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.meegid.2025.105853_bb0710","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1529\/biophysj.107.123620","article-title":"Interaction of LL-37 with model membrane systems of different complexity: influence of the lipid matrix","volume":"94","author":"Sevcsik","year":"2008","journal-title":"Biophys. J."},{"issue":"11","key":"10.1016\/j.meegid.2025.105853_bb0715","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41429-018-0090-7","article-title":"Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus","volume":"71","author":"Shurko","year":"2018","journal-title":"J. Antibiot."},{"issue":"12","key":"10.1016\/j.meegid.2025.105853_bb0720","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1128\/AAC.48.12.4673-4679.2004","article-title":"Degradation of human antimicrobial peptide LL-37 by <i>Staphylococcus aureus<\/i>-derived proteinases","volume":"48","author":"Sieprawska-Lupa","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0725","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/AAC.01583-05","article-title":"In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37","volume":"50","author":"Sigurdardottir","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0730","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2011.09.013","article-title":"The anti-microbial peptide LL-37 modulates immune responses in the palatine tonsils where it is exclusively expressed by neutrophils and a subset of dendritic cells","volume":"142","author":"Sigurdardottir","year":"2012","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.meegid.2025.105853_bb0735","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1462-5822.2011.01644.x","article-title":"Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages","volume":"13","author":"Sonawane","year":"2011","journal-title":"Cell. Microbiol."},{"issue":"12","key":"10.1016\/j.meegid.2025.105853_bb0740","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V97.12.3951","article-title":"Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3","volume":"97","author":"S\u00f8rensen","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0745","article-title":"The effects of antimicrobial peptides WAM-1 and LL-37 on multidrug-resistant Acinetobacter baumannii","volume":"76","author":"Spencer","year":"2018","journal-title":"Pathogens Dis."},{"key":"10.1016\/j.meegid.2025.105853_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-2-2","article-title":"Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides","volume":"2","author":"Steinstraesser","year":"2005","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/biom15010093","article-title":"From cure to crisis: understanding the evolution of antibiotic-resistant bacteria in human microbiota","volume":"15","author":"Tahmasebi","year":"2025","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0760","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1399-302x.2000.150403.x","article-title":"Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophagaspp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium","volume":"15","author":"Tanaka","year":"2000","journal-title":"Oral Microbiol. Immunol."},{"issue":"7","key":"10.1016\/j.meegid.2025.105853_bb0765","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1128\/AAC.01488-05","article-title":"Proteolytic degradation of human antimicrobial peptide LL-37 by <i>Bacillus anthracis<\/i> May contribute to virulence","volume":"50","author":"Thwaite","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124706","article-title":"Antiviral activity of the human cathelicidin, LL-37, and derived peptides on seasonal and pandemic influenza a viruses","volume":"10","author":"Tripathi","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017755","article-title":"Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates","volume":"6","author":"Tsai","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021394","article-title":"Characterizing the role of cell-wall \u03b2-1, 3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37","volume":"6","author":"Tsai","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2025.105853_bb0785","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12275-014-3630-2","article-title":"Responses of Candida albicans to the human antimicrobial peptide LL-37","volume":"52","author":"Tsai","year":"2014","journal-title":"J. Microbiol."},{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0790","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.42.9.2206","article-title":"Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils","volume":"42","author":"Turner","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"15","key":"10.1016\/j.meegid.2025.105853_bb0795","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1128\/JB.187.15.5387-5396.2005","article-title":"Cationic antimicrobial peptide resistance in Neisseria meningitidis","volume":"187","author":"Tzeng","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.meegid.2025.105853_bb0800","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz128","article-title":"Avibactam sensitizes Carbapenem-resistant NDM-1\u2013producing Klebsiella pneumoniae to innate immune clearance","author":"Ulloa","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2025.105853_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171024","article-title":"A review of the antiviral activity of cationic antimicrobial peptides","volume":"166","author":"Urmi","year":"2023","journal-title":"Peptides"},{"issue":"48","key":"10.1016\/j.meegid.2025.105853_bb0810","doi-asserted-by":"crossref","first-page":"37513","DOI":"10.1074\/jbc.M110.134882","article-title":"Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process","volume":"285","author":"Van Der Weerden","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.meegid.2025.105853_bb0815","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molimm.2023.03.011","article-title":"Evolutionary diversification of defensins and cathelicidins in birds and primates","volume":"157","author":"van Dijk","year":"2023","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0820","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.24234","article-title":"Antiviral activity of selected cathelicidins against infectious bronchitis virus","volume":"114","author":"Verheije","year":"2022","journal-title":"Pept. Sci."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0825","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184502","article-title":"Cathelicidin antimicrobial peptide expression in neutrophils and neurons antagonistically modulates neuroinflammation","volume":"135","author":"Verma","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0830","doi-asserted-by":"crossref","DOI":"10.1002\/bip.22871","article-title":"Linear antimicrobial peptides with activity against herpes simplex virus 1 and Aichi virus","volume":"108","author":"Vilas Boas","year":"2017","journal-title":"Pept. Sci."},{"issue":"16","key":"10.1016\/j.meegid.2025.105853_bb0835","article-title":"Antimicrobial peptides of the cathelicidin family: focus on LL-37 and its modifications","volume":"26","author":"Voronko","year":"2025","journal-title":"Int. J. Mol. Sci. [Internet]."},{"issue":"47","key":"10.1016\/j.meegid.2025.105853_bb0840","doi-asserted-by":"crossref","first-page":"32637","DOI":"10.1074\/jbc.M805533200","article-title":"Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.meegid.2025.105853_bb0845","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/AAC.00452-08","article-title":"Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins","volume":"52","author":"Wang","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0850","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1021\/acsinfecdis.1c00096","article-title":"Human cathelicidin inhibits SARS-CoV-2 infection: killing two birds with one stone","volume":"7","author":"Wang","year":"2021","journal-title":"ACS Infect Dis."},{"issue":"8","key":"10.1016\/j.meegid.2025.105853_bb0855","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00018-022-04440-w","article-title":"A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens","volume":"79","author":"White","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0860","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12879-019-3994-3","article-title":"Use of ceragenins as a potential treatment for urinary tract infections","volume":"19","author":"Wnorowska","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"10.1016\/j.meegid.2025.105853_bb0865","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.peptides.2011.04.017","article-title":"Effects of cathelicidin and its fragments on three key enzymes of HIV-1","volume":"32","author":"Wong","year":"2011","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.meegid.2025.105853_bb0870","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007153","article-title":"The C. Difficile clnRAB operon initiates adaptations to the host environment in response to LL-37","volume":"14","author":"Woods","year":"2018","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0875","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/leu.2011.252","article-title":"The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation","volume":"26","author":"Wu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.meegid.2025.105853_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2020.102301","article-title":"Inhibitory effect of LL-37 and human lactoferricin on growth and biofilm formation of anaerobes associated with oral diseases","volume":"67","author":"Wuersching","year":"2021","journal-title":"Anaerobe"},{"issue":"2","key":"10.1016\/j.meegid.2025.105853_bb0885","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20131048","article-title":"Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37","volume":"457","author":"Xhindoli","year":"2013","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0890","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbamem.2015.11.003","article-title":"The human cathelicidin LL-37 \u2014 a pore-forming antibacterial peptide and host-cell modulator","volume":"1858","author":"Xhindoli","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.meegid.2025.105853_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100954","article-title":"Antimicrobial peptides for combating drug-resistant bacterial infections","volume":"68","author":"Xuan","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.meegid.2025.105853_bb0900","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.biochi.2015.11.028","article-title":"Assessing the potential of four cathelicidins for the management of mouse candidiasis and Candida albicans biofilms","volume":"121","author":"Yu","year":"2016","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.meegid.2025.105853_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100999","article-title":"Engineered human cathelicidin antimicrobial peptides inhibit Ebola virus infection","volume":"23","author":"Yu","year":"2020","journal-title":"Iscience"},{"key":"10.1016\/j.meegid.2025.105853_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105021","article-title":"Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding","volume":"187","author":"Yu","year":"2021","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(95)01050-O","article-title":"Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain","volume":"374","author":"Zanetti","year":"1995","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0920","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/0929866529666220929160704","article-title":"The LL-37 antimicrobial peptide as a treatment for systematic infection of Acinetobacter baumannii in a mouse model","volume":"30","author":"Zarei-Mehrvarz","year":"2023","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.meegid.2025.105853_bb0925","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12934-021-01635-x","article-title":"Design and heterologous expression of a novel dimeric LL37 variant in Pichia pastoris","volume":"20","author":"Zhan","year":"2021","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.meegid.2025.105853_bb0930","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jare.2024.02.016","article-title":"Machine learning and genetic algorithm-guided directed evolution for the development of antimicrobial peptides","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.meegid.2025.105853_bb0935","first-page":"9","article-title":"Application of antimicrobial peptides of the innate immune system in combination with conventional antibiotics\u2014a novel way to combat antibiotic resistance?","author":"Zharkova","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.meegid.2025.105853_bb0940","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fcimb.2019.00128","article-title":"Application of antimicrobial peptides of the innate immune system in combination with conventional antibiotics\u2013a novel way to combat antibiotic resistance?","volume":"9","author":"Zharkova","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.meegid.2025.105853_bb0945","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1073\/pnas.1814924116","article-title":"Rigidification of the Escherichia coli cytoplasm by the human antimicrobial peptide LL-37 revealed by superresolution fluorescence microscopy","volume":"116","author":"Zhu","year":"2019","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156713482500142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156713482500142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:37:22Z","timestamp":1768473442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156713482500142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":189,"alternative-id":["S156713482500142X"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2025.105853","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2025.105853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105853"}}